• Tel: 858.663.9055
  • SeparatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
Home >> Antibodies >> DR5 Antibody DR5/3381 / TNFRSF10B Monoclonal Antibody

DR5 Antibody DR5/3381 / TNFRSF10B Monoclonal Antibody [clone DR5/3381] (V8186)

  Catalog No Formulation Size Price (USD)  
Image V8186-100UG 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide 100 ug 559
Image
V8186-20UG 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide 20 ug 259
Image
V8186SAF-100UG 1 mg/ml in 1X PBS; BSA free, sodium azide free 100 ug 559
Microvalidated
Bulk quote request
DR5 Antibody DR5/3381 IHC Staining of Human Breast Carcinoma. Immunohistochemical analysis of FFPE human breast carcinoma tissue using TNFRSF10B Monoclonal Antibody clone DR5/3381. Brown DAB immunoreactivity is observed in tumor cells, with heterogeneous cytoplasmic and membranous staining consistent with the reported cellular distribution of DR5. Heat-induced epitope retrieval was performed by boiling tissue sections in 10 mM Tris with 1 mM EDTA at pH 9 for 20 minutes, followed by cooling before staining.
DR5 Antibody DR5/3381 IHC Staining of Human Colon Carcinoma. Immunohistochemical analysis of FFPE human colon carcinoma tissue using TNFRSF10B Monoclonal Antibody clone DR5/3381. Brown DAB staining is observed in malignant epithelial cells forming glandular structures, with heterogeneous cytoplasmic and membranous immunoreactivity. Heat-induced epitope retrieval was performed by boiling tissue sections in 10 mM Tris with 1 mM EDTA at pH 9 for 20 minutes, followed by cooling before staining.
DR5 Antibody DR5/3381 HuProt Protein Microarray Specificity Analysis. Human protein microarray analysis using TNFRSF10B Monoclonal Antibody clone DR5/3381 on a HuProt array containing more than 19,000 full-length human proteins. TNFRSF10B is identified as the highest-ranked target, with lower-ranked signals associated with CD10 and FAM104A. The graph displays protein signal rank and specificity scores, providing evidence of preferential recognition of TNFRSF10B among the proteins represented on the array.
Species Reactivity Human
Format Purified
Host Mouse
Clonality Monoclonal (mouse origin)
Isotype Mouse IgG1, kappa
Clone Name DR5/3381
Purity Protein G affinity chromatography
UniProt O14763
Localization Cell surface, cytoplasmic
Applications Immunohistochemistry (FFPE): 1-2ug/ml
Limitations This DR5 Antibody DR5/3381 / TNFRSF10B Monoclonal Antibody is available for research use only.
Review this product on BioCompare and get a $20 Amazon gift card

Related Products

Description

DR5 Antibody DR5/3381 / TNFRSF10B Monoclonal Antibody targets death receptor 5 (DR5), a transmembrane protein encoded by the TNFRSF10B gene. Also known as TRAIL receptor 2 (TRAILR2), CD262, and KILLER, DR5 belongs to the tumor necrosis factor receptor superfamily and participates in the regulation of programmed cell death. It binds tumor necrosis factor-related apoptosis-inducing ligand (TRAIL, also called TNFSF10), which can activate the extrinsic apoptotic pathway. DR5 is distinguished from TRAIL decoy receptors by its functional intracellular death domain, which enables the recruitment of signaling proteins required for apoptosis.

DR5 contains extracellular cysteine-rich domains involved in ligand binding, a single transmembrane region, and a cytoplasmic death domain. Binding of TRAIL promotes receptor clustering and assembly of a death-inducing signaling complex (DISC). This complex recruits the adaptor protein FADD and initiator procaspases, particularly procaspase-8, leading to caspase activation. Activated caspase-8 can directly stimulate executioner caspases or cleave BID to engage mitochondrial apoptotic signaling. The resulting cascade promotes the controlled dismantling of cells through programmed cell death.

DR5 signaling is influenced by receptor abundance, intracellular trafficking, post-translational modifications, and the availability of regulatory proteins. Depending on cellular context, TRAIL receptor engagement can also activate non-apoptotic pathways involving NF-kappaB, MAP kinases, and inflammatory signaling. Expression of TNFRSF10B is regulated by several transcriptional mechanisms, including responses to cellular stress and the tumor suppressor p53. These regulatory interactions connect DR5 activity with DNA damage responses, cellular homeostasis, and the elimination of damaged or abnormal cells.

DR5 has attracted considerable attention in cancer biology because TRAIL-mediated apoptosis can contribute to the elimination of malignant cells. However, resistance to TRAIL signaling may arise through altered receptor expression, defective caspase activation, or increased activity of anti-apoptotic proteins. DR5 Antibody DR5/3381 provides a means of investigating TNFRSF10B expression in relation to death receptor signaling, tumor biology, and mechanisms governing cellular sensitivity to apoptosis.

DR5 is an important regulator of apoptosis and a focus of cancer research investigating tumor-cell survival, TRAIL signaling, and resistance to programmed cell death.

Application Notes

Optimal dilution of the DR5 Antibody DR5/3381 / TNFRSF10B Monoclonal Antibody should be determined by the researcher.

Immunogen

A recombinant protein partial protein (amino acids 266-393) was used as the immunogen for this DR5 antibody.

Storage

Store the DR5 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Alternate Names

Death receptor 5 antibody, TRAIL receptor 2 antibody, TRAILR2 antibody, TRAIL R2 antibody, CD262 antibody, KILLER antibody, TNF receptor superfamily member 10B antibody, Tumor necrosis factor receptor superfamily member 10B antibody, TRICK2 antibody, TRICK2A antibody, TRICK2B antibody, DR5 protein antibody

Cross
Bulk Quote Request Form
Name*:
Organization*:
Email*:
Phone Number*:
Catalog No.*:
Comments and Specifics(amount, formulation, etc.)*:
Validation code: Captchapackage Image


Can't read the image? click here to refresh.
    *required field

Your bulk quote request has been submitted successfully!

Please contact us if you have any questions.